HOW TO MAXIMIZE PROCESSING SPACE WHILE PROTECTING AGAINST CROSS CONTAMINATION IN MULTI-PRODUCT FACILITIES
Facility and  Airlock considerations in multi-product facilities to satisfy regulatory and Occupational Exposure issues

 

The session will look at the features commonly found in facilities to prevent the migration of High Hazard compounds through a multi-purpose facility. It will also look at how simple controls can make an “old single door to corridor” facility capable of handling High hazard compounds. Cost and efficiency will be compared as will the risk of over or under engineering solutions.

IIn this webinar we will discuss:
•    Dedication and segregation
•    Facility layout considerations:  new built versus retrofit
•    Segregation for Regulatory issues
•    Facility design concepts
•    Hierarchy of containment boundaries
•    Unit operations off common corridor
•    Ballroom for Pre Compression
•    Ballroom for Process Train
•    Air lock approach
•    Facility costs
•    Access Control
•    Airlocks
•    MAL’s
•    Retrofit Options
•    PAL’s

Instructor:  Julian Wilkins Dip, Arch. (Oxford) RIBA, VP PharmaConsult US, Inc, Adjunct Professor Stevens InstituteJulian Wilkins is founder and vice president with PharmaConsult US, Inc. In 1991 he founded a UK based isolator company for the emerging need for pharmaceutical containment. The company carried out many projects worldwide for aseptic and potent containment at all scales of pharmaceutical operation. He moved to the US in 1997 and set up PharmaConsult US in 1999. Since its formation, the company has provided independent advice, design and support for containment projects including Bristol-Myers Squibb, Chiron, GSK, Merck & Co., Pfizer, Roche Colorado, Sanofi Sythelabo, Tyco/ Mallinckrodt and Wyeth. Wilkins is a past recipient of the prestigious ISPE Member of the Year award. Mr. Wilkins has spoken at many seminars worldwide on the subject of containment and has contributed articles and chapters to periodicals and books on containment.